These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 34899265)
1. Diagnostic Utility of Integrated Chang Y; Liu J; Wang L; Li X; Wang Z; Lin M; Jin W; Zhu M; Xu B Front Aging Neurosci; 2021; 13():721780. PubMed ID: 34899265 [No Abstract] [Full Text] [Related]
2. Imaging of amyloid burden and distribution in cerebral amyloid angiopathy. Johnson KA; Gregas M; Becker JA; Kinnecom C; Salat DH; Moran EK; Smith EE; Rosand J; Rentz DM; Klunk WE; Mathis CA; Price JC; Dekosky ST; Fischman AJ; Greenberg SM Ann Neurol; 2007 Sep; 62(3):229-34. PubMed ID: 17683091 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic utility of amyloid PET in cerebral amyloid angiopathy-related symptomatic intracerebral hemorrhage. Baron JC; Farid K; Dolan E; Turc G; Marrapu ST; O'Brien E; Aigbirhio FI; Fryer TD; Menon DK; Warburton EA; Hong YT J Cereb Blood Flow Metab; 2014 May; 34(5):753-8. PubMed ID: 24619277 [TBL] [Abstract][Full Text] [Related]
4. Cerebral amyloid angiopathy burden associated with leukoaraiosis: a positron emission tomography/magnetic resonance imaging study. Gurol ME; Viswanathan A; Gidicsin C; Hedden T; Martinez-Ramirez S; Dumas A; Vashkevich A; Ayres AM; Auriel E; van Etten E; Becker A; Carmasin J; Schwab K; Rosand J; Johnson KA; Greenberg SM Ann Neurol; 2013 Apr; 73(4):529-36. PubMed ID: 23424091 [TBL] [Abstract][Full Text] [Related]
5. Quantitative longitudinal interrelationships between brain metabolism and amyloid deposition during a 2-year follow-up in patients with early Alzheimer's disease. Förster S; Yousefi BH; Wester HJ; Klupp E; Rominger A; Förstl H; Kurz A; Grimmer T; Drzezga A Eur J Nucl Med Mol Imaging; 2012 Dec; 39(12):1927-36. PubMed ID: 22926714 [TBL] [Abstract][Full Text] [Related]
6. Cerebral Amyloid Angiopathy Pathology and Its Association With Amyloid-β PET Signal. McCarter SJ; Lesnick TG; Lowe V; Mielke MM; Constantopoulos E; Rabinstein AA; Przybelski SA; Botha H; Jones DT; Ramanan VK; Jack CR; Petersen RC; Knopman D; Boeve BF; Murray ME; Dickson DW; Vemuri P; Kantarci K; Reichard RR; Graff-Radford J Neurology; 2021 Nov; 97(18):e1799-e1808. PubMed ID: 34504022 [TBL] [Abstract][Full Text] [Related]
7. Cerebral microbleeds: Prevalence and relationship to amyloid burden. Graff-Radford J; Botha H; Rabinstein AA; Gunter JL; Przybelski SA; Lesnick T; Huston J; Flemming KD; Preboske GM; Senjem ML; Brown RD; Mielke MM; Roberts RO; Lowe VJ; Knopman DS; Petersen RC; Kremers W; Vemuri P; Jack CR; Kantarci K Neurology; 2019 Jan; 92(3):e253-e262. PubMed ID: 30568001 [TBL] [Abstract][Full Text] [Related]
10. Florbetapir-PET to diagnose cerebral amyloid angiopathy: A prospective study. Gurol ME; Becker JA; Fotiadis P; Riley G; Schwab K; Johnson KA; Greenberg SM Neurology; 2016 Nov; 87(19):2043-2049. PubMed ID: 27605173 [TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of cerebral microbleeds: In vivo imaging of amyloid and subcortical ischemic small vessel disease in 226 individuals with cognitive impairment. Park JH; Seo SW; Kim C; Kim GH; Noh HJ; Kim ST; Kwak KC; Yoon U; Lee JM; Lee JW; Shin JS; Kim CH; Noh Y; Cho H; Kim HJ; Yoon CW; Oh SJ; Kim JS; Choe YS; Lee KH; Lee JH; Ewers M; Weiner MW; Werring DJ; Na DL Ann Neurol; 2013 May; 73(5):584-93. PubMed ID: 23495089 [TBL] [Abstract][Full Text] [Related]
13. Evaluating [ Zhang Q; Zhao X; Lei P; Kung HF; Yang Z; Zhu L; Wang S; Zhu H; Meng X; Duan Y; Sun L; Pan J; Ma R; Hong H; Zhao X; Demchuk A; Smith EE; Wang Y Front Neurol; 2021; 12():702185. PubMed ID: 34777194 [No Abstract] [Full Text] [Related]
14. Florbetapir Regional Distribution in Cerebral Amyloid Angiopathy and Alzheimer's Disease: A PET Study. Planton M; Saint-Aubert L; Raposo N; Payoux P; Salabert AS; Albucher JF; Olivot JM; Péran P; Pariente J J Alzheimers Dis; 2020; 73(4):1607-1614. PubMed ID: 31958082 [TBL] [Abstract][Full Text] [Related]
15. 11C-PIB binding is increased in patients with cerebral amyloid angiopathy-related hemorrhage. Ly JV; Donnan GA; Villemagne VL; Zavala JA; Ma H; O'Keefe G; Gong SJ; Gunawan RM; Saunder T; Ackerman U; Tochon-Danguy H; Churilov L; Phan TG; Rowe CC Neurology; 2010 Feb; 74(6):487-93. PubMed ID: 20142615 [TBL] [Abstract][Full Text] [Related]
16. Cerebral Microbleeds, Cerebrospinal Fluid, and Neuroimaging Markers in Clinical Subtypes of Alzheimer's Disease. Ikeda M; Kodaira S; Kasahara H; Takai E; Nagashima K; Fujita Y; Makioka K; Hirayanagi K; Furuta N; Furuta M; Sanada E; Kobayashi A; Harigaya Y; Nagamine S; Hattori N; Tashiro Y; Kishi K; Shimada H; Suto T; Tanaka H; Sakai Y; Yamazaki T; Tanaka Y; Aihara Y; Amari M; Yamaguchi H; Okamoto K; Takatama M; Ishii K; Higuchi T; Tsushima Y; Ikeda Y Front Neurol; 2021; 12():543866. PubMed ID: 33889121 [TBL] [Abstract][Full Text] [Related]
17. Imaging of amyloid deposition in human brain using positron emission tomography and [18F]FACT: comparison with [11C]PIB. Ito H; Shinotoh H; Shimada H; Miyoshi M; Yanai K; Okamura N; Takano H; Takahashi H; Arakawa R; Kodaka F; Ono M; Eguchi Y; Higuchi M; Fukumura T; Suhara T Eur J Nucl Med Mol Imaging; 2014 Apr; 41(4):745-54. PubMed ID: 24233004 [TBL] [Abstract][Full Text] [Related]
18. Differences in lobar microbleed topography in cerebral amyloid angiopathy and hypertensive arteriopathy. Kuo PY; Tsai HH; Lee BC; Chiang PT; Liu CJ; Chen YF; Jeng JS; Yen RF; Tsai LK Sci Rep; 2024 Feb; 14(1):3774. PubMed ID: 38355951 [TBL] [Abstract][Full Text] [Related]
20. Use of T1-weighted/T2-weighted magnetic resonance ratio to elucidate changes due to amyloid β accumulation in cognitively normal subjects. Yasuno F; Kazui H; Morita N; Kajimoto K; Ihara M; Taguchi A; Yamamoto A; Matsuoka K; Takahashi M; Nakagawara J; Iida H; Kishimoto T; Nagatsuka K Neuroimage Clin; 2017; 13():209-214. PubMed ID: 28003959 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]